Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
69
FXNC Quote, Financials, Valuation and Earnings
Last price:
$24.13
Seasonality move
:
4.28%
Day range:
$23.98 - $24.88
52-week range:
$14.50 - $26.00
Dividend yield:
2.48%
P/E ratio:
21.76x
P/S ratio:
2.72x
P/B ratio:
1.75x
Volume:
160.4K
Avg. volume:
24.9K
1-year change:
17.22%
Market cap:
$218.6M
Revenue:
$53.6M
EPS (TTM):
$1.12
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $35.7M | $36.7M | $43.9M | $56.9M | $53.6M | |
| Revenue Growth (YoY) | -0.86% | 2.94% | 19.49% | 29.61% | -5.77% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $14.3M | $13.9M | $18.8M | $22M | $22.6M | |
| Other Inc / (Exp) | $1K | $40K | $37K | $881K | $186K | |
| Operating Expenses | $14.6M | $14.1M | $18.8M | $22M | $22.6M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $11.8M | $10.9M | $12.9M | $20.7M | $11.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.2M | $2M | $2.6M | $4M | $2.2M | |
| Net Income to Company | $9.6M | $8.9M | $10.4M | $16.8M | $9.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9.6M | $8.9M | $10.4M | $16.8M | $9.6M | |
| Basic EPS (Cont. Ops) | $1.92 | $1.82 | $1.87 | $2.69 | $1.54 | |
| Diluted EPS (Cont. Ops) | $1.92 | $1.82 | $1.86 | $2.68 | $1.53 | |
| Weighted Average Basic Share | $5M | $4.9M | $5.6M | $6.3M | $6.3M | |
| Weighted Average Diluted Share | $5M | $4.9M | $5.6M | $6.3M | $6.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $16.7M | $14.3M | $15.2M | $24.6M | $26.1M | |
| Revenue (Reported) | $35.7M | $36.7M | $43.9M | $56.9M | $53.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $16.7M | $14.3M | $15.2M | $24.6M | $26.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $9.5M | $12.1M | $14.4M | $13.3M | $14.6M | |
| Revenue Growth (YoY) | 5.3% | 26.7% | 19.62% | -7.81% | 9.49% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.6M | $5.8M | $5.5M | $5.9M | $6.4M | |
| Other Inc / (Exp) | $38K | -- | -- | -- | $39K | |
| Operating Expenses | $3.6M | $5.8M | $5.5M | $5.9M | $6.4M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.1M | $3M | $5.5M | $3.9M | $2.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $386K | $562K | $1M | $731K | $545K | |
| Net Income to Company | $1.8M | $2.4M | $4.5M | $3.1M | $2.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.8M | $2.4M | $4.5M | $3.1M | $2.2M | |
| Basic EPS (Cont. Ops) | $0.36 | $0.39 | $0.71 | $0.50 | $0.36 | |
| Diluted EPS (Cont. Ops) | $0.36 | $0.38 | $0.71 | $0.50 | $0.36 | |
| Weighted Average Basic Share | $4.9M | $6.2M | $6.3M | $6.3M | $6.3M | |
| Weighted Average Diluted Share | $4.9M | $6.2M | $6.3M | $6.3M | $6.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.9M | $3.6M | $6.5M | $7.8M | $8.5M | |
| Revenue (Reported) | $9.5M | $12.1M | $14.4M | $13.3M | $14.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.9M | $3.6M | $6.5M | $7.8M | $8.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $36.5M | $40.5M | $53.8M | $55.8M | $56.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $13.8M | $16.8M | $21.8M | $22.9M | $24.3M | |
| Other Inc / (Exp) | $39K | $39K | -- | $881K | $225K | |
| Operating Expenses | $13.9M | $16.9M | $21.8M | $22.9M | $24.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $10.4M | $14.2M | $17.5M | $18.9M | $8.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9M | $2.8M | $3.3M | $3.6M | $1.7M | |
| Net Income to Company | $8.4M | $11.3M | $14.2M | $15.3M | $7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $8.4M | $11.3M | $14.2M | $15.3M | $7M | |
| Basic EPS (Cont. Ops) | $1.71 | $2.23 | $2.27 | $2.43 | $1.12 | |
| Diluted EPS (Cont. Ops) | $1.71 | $2.22 | $2.27 | $2.43 | $1.12 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $14.3M | $16.5M | $20.2M | $30.5M | $30M | |
| Revenue (Reported) | $36.5M | $40.5M | $53.8M | $55.8M | $56.4M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $14.3M | $16.5M | $20.2M | $30.5M | $30M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $27.4M | $31.1M | $41.1M | $40.1M | $42.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $10.5M | $13.4M | $16.4M | $17.2M | $18.9M | |
| Other Inc / (Exp) | $38K | $37K | -- | -- | $39K | |
| Operating Expenses | $10.6M | $13.4M | $16.4M | $17.3M | $18.9M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $7M | $10.3M | $14.8M | $13M | $9.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.3M | $2.1M | $2.8M | $2.5M | $2M | |
| Net Income to Company | $5.7M | $8.2M | $12M | $10.5M | $7.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $5.7M | $8.2M | $12M | $10.5M | $7.9M | |
| Basic EPS (Cont. Ops) | $1.16 | $1.58 | $1.92 | $1.67 | $1.26 | |
| Diluted EPS (Cont. Ops) | $1.16 | $1.57 | $1.92 | $1.67 | $1.26 | |
| Weighted Average Basic Share | $14.7M | $16M | $18.7M | $18.8M | $18.8M | |
| Weighted Average Diluted Share | $14.7M | $16M | $18.8M | $18.8M | $18.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $9.7M | $12M | $16.9M | $22.8M | $26.7M | |
| Revenue (Reported) | $27.4M | $31.1M | $41.1M | $40.1M | $42.9M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $9.7M | $12M | $16.9M | $22.8M | $26.7M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $45.8M | $127.3M | $176M | $66.9M | $87.2M | |
| Short Term Investments | $121M | $140.2M | $289.5M | $162.9M | $152.9M | |
| Accounts Receivable, Net | $2.1M | $2.7M | $3.9M | $4.5M | $4.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $168.8M | $270.2M | $469.4M | $234.4M | $244.7M | |
| Property Plant And Equipment | $19.7M | $19.3M | $22.4M | $21.9M | $22.1M | |
| Long-Term Investments | $138.6M | $154.5M | $322.9M | $316.1M | $301.1M | |
| Goodwill | -- | -- | $3M | $3M | $3M | |
| Other Intangibles | $170K | $19K | $154K | $136K | $117K | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $800M | $950.9M | $1.4B | $1.4B | $1.4B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $50M | |
| Long-Term Debt | $14.3M | $19.3M | $19.3M | $14.3M | $14.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $722.8M | $866M | $1.3B | $1.3B | $1.3B | |
| Common Stock | $6.2M | $6.1M | $7.8M | $7.8M | $7.8M | |
| Other Common Equity Adj | $724K | $3.4M | $298K | -$22.5M | -$18.7M | |
| Common Equity | $77.2M | $84.9M | $117M | $108.4M | $116.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $77.2M | $84.9M | $117M | $108.4M | $116.3M | |
| Total Liabilities and Equity | $800M | $950.9M | $1.4B | $1.4B | $1.4B | |
| Cash and Short Terms | $166.8M | $267.5M | $465.5M | $229.8M | $240M | |
| Total Debt | $14.3M | $19.3M | $19.3M | $14.3M | $64.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $122.2M | $114.6M | $75.8M | $50.1M | $126.5M | |
| Short Term Investments | $117.1M | $266.6M | $176.4M | $148.2M | $146M | |
| Accounts Receivable, Net | $3.2M | $3.8M | $4.2M | $4.5M | $4.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $242.5M | $465.7M | $256.4M | $202.8M | $277.3M | |
| Property Plant And Equipment | $19.5M | $22.4M | $21.7M | $21.4M | $23M | |
| Long-Term Investments | $132.2M | $276.6M | $331.3M | $298.1M | $267.4M | |
| Goodwill | -- | $4M | $3M | $3M | $3M | |
| Other Intangibles | $43K | $159K | $140K | $122K | $104K | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $942.7M | $1.4B | $1.4B | $1.4B | $1.5B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $19.3M | $19.3M | $14.3M | $14.3M | $64.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $860.5M | $1.2B | $1.3B | $1.3B | $1.3B | |
| Common Stock | $6.1M | $7.8M | $7.8M | $7.8M | $7.9M | |
| Other Common Equity Adj | $3.4M | $1.7M | -$27.8M | -$24.7M | -$15.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $82.3M | $116.9M | $99.1M | $112M | $125.1M | |
| Total Liabilities and Equity | $942.7M | $1.4B | $1.4B | $1.4B | $1.5B | |
| Cash and Short Terms | $239.3M | $381.2M | $252.2M | $198.3M | $272.5M | |
| Total Debt | $19.3M | $19.3M | $14.3M | $14.3M | $64.3M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.6M | $8.9M | $10.4M | $16.8M | $9.6M | |
| Depreciation & Amoritzation | $1.6M | $1.5M | $1.4M | $1.5M | $1.6M | |
| Stock-Based Compensation | $183K | $290K | $354K | $785K | $753K | |
| Change in Accounts Receivable | $48K | -$652K | $545K | -$640K | -$112K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $11.9M | $15.1M | $7.9M | $26.8M | $16.4M | |
| Capital Expenditures | $1M | $909K | $835K | $1.2M | $1.9M | |
| Cash Acquisitions | -- | -- | -$44.3M | -- | -- | |
| Cash From Investing | -$28.9M | -$70.5M | -$126.3M | -$120.1M | -$34.3M | |
| Dividends Paid (Ex Special Dividend) | -$1.7M | -$2M | -$2.5M | -$3.3M | -$3.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $5M | -- | -- | $50M | |
| Long-Term Debt Repaid | -- | -- | -- | -$5M | -- | |
| Repurchase of Common Stock | -$20K | -$2.1M | -$39K | -$183K | -$682K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $34.2M | $136.9M | $167.1M | -$15.7M | $38.2M | |
| Beginning Cash (CF) | $28.6M | $45.8M | $127.3M | $176M | $66.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $17.2M | $81.5M | $48.7M | -$109.1M | $20.2M | |
| Ending Cash (CF) | $45.8M | $127.3M | $176M | $66.9M | $87.2M | |
| Levered Free Cash Flow | $10.8M | $14.2M | $7M | $25.6M | $14.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.8M | $2.4M | $4.5M | $3.1M | $2.2M | |
| Depreciation & Amoritzation | $371K | $368K | $376K | $405K | $452K | |
| Stock-Based Compensation | $86K | $181K | $187K | $274K | $264K | |
| Change in Accounts Receivable | $707K | $398K | -$93K | -$254K | $122K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5M | $12.9M | $4.6M | $3.4M | $6.1M | |
| Capital Expenditures | $94K | $417K | $192K | $207K | $1.2M | |
| Cash Acquisitions | -- | $37.6M | -- | -- | -- | |
| Cash From Investing | $10.1M | -$87.4M | -$22.3M | -$17.3M | -$1.8M | |
| Dividends Paid (Ex Special Dividend) | -$499K | -$706K | -$828K | -$898K | -$896K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $39K | -- | -$62K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$1.1M | $60.9M | -$30.9M | -$8.1M | -$13.4M | |
| Beginning Cash (CF) | $108.3M | $128.2M | $124.4M | $72.1M | $135.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $13.9M | -$13.6M | -$48.6M | -$22M | -$9.1M | |
| Ending Cash (CF) | $122.2M | $114.6M | $75.8M | $50.1M | $126.5M | |
| Levered Free Cash Flow | $4.9M | $12.5M | $4.4M | $3.2M | $4.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8.4M | $11.3M | $14.2M | $15.3M | $7M | |
| Depreciation & Amoritzation | $1.5M | $1.4M | $1.5M | $1.6M | $1.7M | |
| Stock-Based Compensation | $278K | $336K | $782K | $738K | $538K | |
| Change in Accounts Receivable | -$1.1M | $892K | -$252K | -$255K | -$292K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $14M | $18.4M | $12.4M | $21.2M | $19.6M | |
| Capital Expenditures | $940K | $738K | $809K | $1.3M | $3.3M | |
| Cash Acquisitions | -- | $37.6M | -$81.9M | -- | -- | |
| Cash From Investing | -$76M | -$161.1M | -$96.6M | -$11.9M | -$7.6M | |
| Dividends Paid (Ex Special Dividend) | -$1.9M | -$2.3M | -$3.2M | -$3.5M | -$3.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$2.1M | -- | -$222K | -$682K | -$98K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $153.8M | $135.2M | $45.3M | -$35M | $64.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $91.8M | -$7.6M | -$38.9M | -$25.7M | $76.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $13.1M | $17.6M | $11.6M | $20M | $16.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $5.7M | $8.2M | $12M | $10.5M | $7.9M | |
| Depreciation & Amoritzation | $1.1M | $1M | $1.1M | $1.2M | $1.3M | |
| Stock-Based Compensation | $254K | $300K | $728K | $681K | $466K | |
| Change in Accounts Receivable | -$1.1M | $453K | -$344K | $41K | -$139K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $9.1M | $12.3M | $16.8M | $11.3M | $14.5M | |
| Capital Expenditures | $793K | $622K | $596K | $682K | $2.2M | |
| Cash Acquisitions | -- | $37.6M | -- | -- | -- | |
| Cash From Investing | -$66M | -$156.6M | -$126.9M | -$18.7M | $8.1M | |
| Dividends Paid (Ex Special Dividend) | -$1.5M | -$1.8M | -$2.5M | -$2.7M | -$2.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $5M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$5M | -- | -- | |
| Repurchase of Common Stock | -$2.1M | -- | -$183K | -$682K | -$98K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $133.3M | $131.6M | $9.8M | -$9.5M | $16.8M | |
| Beginning Cash (CF) | $202.2M | $431.8M | $450.2M | $216.8M | $361.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $76.4M | -$12.7M | -$100.2M | -$16.8M | $39.4M | |
| Ending Cash (CF) | $278.6M | $419.2M | $350M | $200M | $400.9M | |
| Levered Free Cash Flow | $8.3M | $11.7M | $16.2M | $10.6M | $12.3M | |
Get FXNC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FXNC
Sector
P/E ratio
21.76x
11.99x
PEG ratio
--
0.36x
P/B ratio
1.75x
1.05x
Price / LTM sales
2.72x
2.55x
Growth Metrics
FXNC
Sector
Revenue growth
9.49%
6.08%
Earnings growth
-28%
6.45%
Revenue (5-year growth)
8.29%
5.85%
Earnings forecast
$0.48
$0.56
Profitability
FXNC
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
4.09%
5.27%
Return on assets
0.49%
0.98%
Return on equity
5.96%
9.43%
Earnings Date
Last Earnings Date
Nov
1
Next Earnings Date
Jan
31
Estimated Next Earnings Date
Jan
31
Balance Sheet
FXNC
Sector
Total cash
$272.5M
$615.3M
Short term investments
$152.9M
$408.4M
Total assets
$1.4B
$4.5B
Long term debt
$64.3M
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
